FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

TWOMEY CHRISTOPHER J
2. Issuer Name and Ticker or Trading Symbol

Bionano Genomics, Inc [ BNGO ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100
3. Date of Earliest Transaction (MM/DD/YYYY)

4/6/2020
(Street)

SAN DIEGO, CA 92121
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 4/6/2020  A(1)  45000 A$0.32 (2)64500 I C J TWOMEY & R J TWOMEY TTEES, C J & R J TWOMEY FAMILY TRUST, UAD 9/20/2002 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Common Stock Warrants (right to buy) $0.33 4/6/2020  A (1)  45000    4/6/2020 4/6/2025 Common Stock 45000 $0.01 (2)45000 I C J TWOMEY & R J TWOMEY TTEES, C J & R J TWOMEY FAMILY TRUST, UAD 9/20/2002 

Explanation of Responses:
(1) Acquired from the Issuer pursuant to an Underwriting Agreement dated April 1, 2020 with a closing date of April 6, 2020. The Underwriting Agreement and the issuance of the securities thereunder was approved by the Issuer's Board of Directors.
(2) The total per share and accompanying common warrant price offered in the public offering is $0.33. Each share of common stock is being sold together with a common warrant to purchase one share of the Company's common stock. The public offering price, per share is $0.32 and per common warrant is $0.01.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
TWOMEY CHRISTOPHER J
C/O BIONANO GENOMICS, INC.
9540 TOWNE CENTRE DRIVE, SUITE 100
SAN DIEGO, CA 92121
X



Signatures
/s/ Heather Adams, Attorney-in-fact4/7/2020
**Signature of Reporting PersonDate

Bionano Genomics (NASDAQ:BNGO)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Bionano Genomics Charts.
Bionano Genomics (NASDAQ:BNGO)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Bionano Genomics Charts.